Advertisement

AIDS and Behavior

, Volume 23, Issue 6, pp 1541–1551 | Cite as

The Intersection of HIV, Social Vulnerability, and Reproductive Health: Analysis of Women Living with HIV in Rio de Janeiro, Brazil from 1996 to 2016

  • Christine M. ZachekEmail author
  • Lara E. Coelho
  • Rosa M. S. M. Domingues
  • Jesse L. Clark
  • Raquel B. De Boni
  • Paula M. Luz
  • Ruth K. Friedman
  • Ângela C. Vasconcelos de Andrade
  • Valdilea G. Veloso
  • Jordan E. Lake
  • Beatriz Grinsztejn
Original Paper

Abstract

Comprehensive care for sexual and reproductive health (SRH) and social needs for women living with HIV remains limited globally. We aimed to assess trends in baseline sociodemographic, clinical, sexual, and reproductive characteristics among a cohort of HIV-infected women in Rio de Janeiro from 1996 to 2016. Participants were stratified into four time periods based on year of enrollment; we compared cross-sectional data from each period. Of 1361 participants (median age 36), most were black or mixed race (60.1%), unemployed (52.1%), and without secondary education (54%). Adolescent pregnancy was common (51.5%), and 18.3% reported sexual debut at < 15 years old. Nearly half (45.2%) had < 5 lifetime sexual partners, yet prior syphilis and oncogenic human papillomavirus prevalence were 10.9% and 43.1%, respectively. Lifetime prevalence of induced abortion was 30.3%, and 16% used no contraceptive method. Future research should explore interactions between social vulnerability, HIV, and poor SRH outcomes and healthcare models to alleviate these disparities.

Keywords

HIV Sexual and reproductive health Women Disparities Brazil 

Resumen

La atención integral de la salud sexual y reproductiva (SSR) y necesidades sociales para las mujeres que viven con VIH ha estado limitada al nivel global. Nuestro objetivo fue evaluar las tendencias de características sociodemográficas, clínicas, sexuales y reproductivas en una cohorte de mujeres infectadas por VIH en Río de Janeiro entre 1996 y 2016. Los participantes se estratificaron en cuatro períodos de tiempo según el año de enrolamiento; comparamos datos transversales de cada período. De 1361 participantes (mediana de edad 36), la mayoría eran negras o de raza mixta (60,1%), desempleadas (52,1%) y no tenían educación secundaria (54%). El embarazo en la adolescencia fue común (51,5%) y el 18,3% reportaron iniciación sexual antes de los 15 años de edad. Casi la mitad (45,2%) tenían menos de 5 parejas sexuales durante sus vidas, sin embargo, la prevalencia de la sífilis previa y del virus del papiloma humano oncogénico fue del 10,9% y 43,1%, respectivamente. La prevalencia de vida de aborto inducido fue 30,3% y el 16% no utilizaron ningún método anticonceptivo. Futuras investigaciones deberían explorar las interacciones entre la vulnerabilidad social, el VIH y los resultados adversos de SSR y los modelos de cuidado de la salud para aliviar estas disparidades.

Palabras clave

VIH Salud sexual y reproductiva Mujeres Disparidades Brasil 

Notes

Acknowledgements

We would like to thank the INI-Fiocruz study participants and staff who devoted their time and efforts to make this project possible. We would also like to thank Eddy Segura for his assistance with abstract translation.

Funding

This work was supported in part by the Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at the University of California San Francisco. CMZ is a Doris Duke International Clinical Research Fellow. This work was also supported by the US National Institute of Health Grants NIH R25 MH087222 to JLC and K23 AI110532 to JEL. RBDB acknowledges funding from the Research Funding Agency of the State of Rio de Janeiro (FAPERJ) E-26/203.154/2017 and from the National Council of Technological and Scientific Development (CNPq) 310541/2017-4.

Compliance with Ethical Standards

Conflict of interest

The authors have no conflicts of interest to declare.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    UNAIDS Data 2017 [Internet]. Joint United Nations Programme on HIV/AIDS (UNAIDS); 2017 [cited 2018 Apr 21]. http://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf.
  2. 2.
    Boletim epidemiológico de AIDS e DST [Internet]. Brasília (BR): Ministério da Saúde. Secretaria de Vigilância em Saúde—Departamento de DST, Aids e Hepatites Virais; 2016 [cited 2018 Apr 20]. http://www.aids.gov.br/ptbr/pub/2016/boletim-epidemiologico-de-aids-2016.
  3. 3.
    Fonseca MG, Bastos FI. Twenty-five years of the AIDS epidemic in Brazil: principal epidemiological findings, 1980–2005. Cad Saude Publ. 2007;23(Suppl 3):S333–44.Google Scholar
  4. 4.
    Consolidated guideline on sexual and reproductive health and rights of women living with HIV [Internet]. Geneva (CH): World Health Organization; 2017 [cited 2018 Apr 21]. http://www.who.int/reproductivehealth/publications/gender_rights/srhr-women-hiv/en/.
  5. 5.
    Loutfy MR, Sherr L, Sonnenberg-Schwan U, et al. Caring for women living with HIV: gaps in the evidence. J Int AIDS Soc. 2013;16:18509.Google Scholar
  6. 6.
    Pinho AA, Cabral CDS, Barbosa RM. Differences and similarities in women living and not living with HIV: contributions by the GENIH study to sexual and reproductive healthcare. Cad Saude Publ. 2017;33(12):e00057916.Google Scholar
  7. 7.
    Bekker LG, Alleyne G, Baral S, et al. Advancing global health and strengthening the HIV response in the era of the sustainable development goals: the International AIDS Society-Lancet Commission. Lancet. 2018;392(10144):312–58.Google Scholar
  8. 8.
    Fiore S, Heard I, Thorne C, et al. Reproductive experience of HIV-infected women living in Europe. Hum Reprod. 2008;23(9):2140–4.Google Scholar
  9. 9.
    Heffron R, Thomson K, Celum C, et al. Fertility intentions, pregnancy, and use of PrEP and ART for safer conception among East African HIV serodiscordant couples. AIDS Behav. 2018;22(6):1758–65.Google Scholar
  10. 10.
    Haddad LB, Wall KM, Mehta CC, et al. Trends of and factors associated with live-birth and abortion rates among HIV-positive and HIV-negative women. Am J Obstet Gynecol. 2017;216(1):71.e1–16.Google Scholar
  11. 11.
    Orza L, Welbourn A, Bewley S, Crone ET, Vazquez M. Building a safe house on firm ground: key findings from a global values and preferences survey regarding the sexual and reproductive health and human rights of women living with HIV [Internet]. Geneva (CH): Salamander Trust; 2014 [cited 2018 Apr 20]. http://salamandertrust.net/wp-content/uploads/2016/09/BuildingASafeHouseOnFirmGroundFINALreport190115.pdf.
  12. 12.
    de Fatima Bonolo P, Ceccato M, Rocha GM, de Assis Acurcio F, Campos LN, Guimarães MD. Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy. Clinics. 2013;68(5):612–20.Google Scholar
  13. 13.
    Hipolito RL, Oliveira DC, Costa TLD, Marques SC, Pereira ER, Gomes AMT. Quality of life of people living with HIV/AIDS: temporal, socio-demographic and perceived health relationship. Rev Lat Am Enferm. 2017;25:e2874.Google Scholar
  14. 14.
    Prevention gap report [Internet]. Joint United Nations programme on HIV/AIDS (UNAIDS); 2016 [cited 2018 Nov 24]. http://www.unaids.org/sites/default/files/media_asset/2016-prevention-gap-report_en.pdf.
  15. 15.
    Stewart DE, Aviles R, Guedes A, Riazantseva E, MacMillan H. Latin American and Caribbean countries’ baseline clinical and policy guidelines for responding to intimate partner violence and sexual violence against women. BMC Public Health. 2015;15:665.Google Scholar
  16. 16.
    Molinatti F, Acosta LD. Trends in mortality by assault in women in selected countries of Latin America, 2001–2011. Rev Panam Salud Publ. 2015;37(4–5):279–86.Google Scholar
  17. 17.
    Meyer JP, Womack JA, Gibson B. Beyond the pap smear: gender-responsive HIV care for women. Yale J Biol Med. 2016;89(2):193–203.Google Scholar
  18. 18.
    Johnson M, Samarina A, Xi H, et al. Barriers to access to care reported by women living with HIV across 27 countries. AIDS Care. 2015;27(10):1220–30.Google Scholar
  19. 19.
    Meyer JP, Springer SA, Altice FL. Substance abuse, violence, and HIV in women: a literature review of the syndemic. J Womens Health. 2011;20(7):991–1006.Google Scholar
  20. 20.
    Kapetanovic S, Dass-Brailsford P, Nora D, Talisman N. Mental health of HIV-seropositive women during pregnancy and postpartum period: a comprehensive literature review. AIDS Behav. 2014;18(6):1152–73.Google Scholar
  21. 21.
    Sun M, Peipert JF, Zhao Q, et al. Trends in contraceptive use among women with human immunodeficiency virus. Obstet Gynecol. 2012;120(4):783–90.Google Scholar
  22. 22.
    Iyun V, Brittain K, Phillips TK, et al. Prevalence and determinants of unplanned pregnancy in HIV-positive and HIV-negative pregnant women in Cape Town, South Africa: a cross-sectional study. BMJ Open. 2018;8(4):e019979.Google Scholar
  23. 23.
    Pilecco FB, Teixeira LB, Vigo A, Dewey ME, Knauth DR. Lifetime induced abortion: a comparison between women living and not living with HIV. PLoS ONE. 2014;9(4):e95570.Google Scholar
  24. 24.
    Santos NJ, Barbosa RM, Pinho AA, Villela WV, Aidar T, Filipe EM. Contexts of HIV vulnerability among Brazilian women. Cad Saude Publ. 2009;25(Suppl 2):S321–33.Google Scholar
  25. 25.
    Teixeira LB, Pilecco FB, Vigo A, Knauth DR. Sexual and reproductive health of women living with HIV in Southern Brazil. Cad Saude Publ. 2013;29(3):609–20.Google Scholar
  26. 26.
    Adolescent pregnancy: issues in adolescent health and development [Internet]. Geneva (CH): World Health Organization; 2004 [cited 2018 Apr 20]. http://apps.who.int/iris/bitstream/handle/10665/42903/9241591455_eng.pdf;jsessionid=8857E245337E0607B1B6F170D2C1227E?sequence=1.
  27. 27.
    Vigitel Brasil 2016: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico: estimativas sobre frequência e distribuição sociodemográfica de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2016 [Internet]. Brasília (BR): Ministério da Saúde. Secretaria de Vigilância em Saúde—Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde; 2017 [cited 2018 May 9]. http://portalarquivos2.saude.gov.br/images/pdf/2018/marco/02/vigitel-brasil-2016.pdf.
  28. 28.
    II Levantamento domiciliar sobre o uso de drogas psicotrópicas no Brasil: Estudo envolvendo as 108 maiores cidades do país: 2005 [Internet]. São Paulo (BR): Secretaria Nacional Antidrogas, Gabinete de Segurança Institucional; 2006 [cited 2018 Apr 23]. https://www.cebrid.com.br/ii-levantamento-domiciliar-2005/. Joint publication of Centro Brasileiro de Informação sobre Drogas Psicotrópicas and Universidade Federal de São Paulo.
  29. 29.
    Okie S. Fighting HIV–lessons from Brazil. N Engl J Med. 2006;354(19):1977–81.Google Scholar
  30. 30.
    Boletim epidemiológico DST/AIDS [Internet]. Secretaria Municipal de Saúde, Prefeitura do Rio de Janeiro. Subsecretaria de Atenção Primária, Vigilância e Promoção da Saúde. Gerência de DST/AIDS e Hepatites Virais; 2013 [cited 2018 Apr 23]. http://www.rio.rj.gov.br/dlstatic/10112/4502878/4114721/anexo1_boletim.indd.pdf.
  31. 31.
    Mujica OJ, Vazquez E, Duarte EC, Cortez-Escalante JJ, Molina J, da Silva Junior JB. Socioeconomic inequalities and mortality trends in BRICS, 1990–2010. Bull World Health Organ. 2014;92(6):405–12.Google Scholar
  32. 32.
    Pesquisa de conhecimentos, atitudes e práticas na população brasileira—PCAP 2013 [Internet]. Brasília (BR): Ministério da Saúde. Secretaria de Vigilância em Saúde—Departamento de DST, Aids e Hepatites Virais; 2016 [cited 2018 Apr 23]. http://www.aids.gov.br/pt-br/pub/2016/pesquisa-de-conhecimentos-atitudes-epraticas-na-populacao-brasileira-pcap-2013.
  33. 33.
    Wellings K, Collumbien M, Slaymaker E, et al. Sexual behaviour in context: a global perspective. Lancet. 2006;368(9548):1706–28.Google Scholar
  34. 34.
    Vaz RF, Monteiro DL, Rodrigues NC. Trends of teenage pregnancy in Brazil, 2000–2011. Rev Assoc Med Bras. 2016;62(4):330–5.Google Scholar
  35. 35.
    Tejada CA, Triaca LM, da Costa FK, Hellwig F. The sociodemographic, behavioral, reproductive, and health factors associated with fertility in Brazil. PLoS ONE. 2017;12(2):e0171888.Google Scholar
  36. 36.
    Domingues RM, Szwarcwald CL, Souza Junior PR, Leal MC. Prevalence of syphilis in pregnancy and prenatal syphilis testing in Brazil: birth in Brazil study. Rev Saude Publ. 2014;48(5):766–74.Google Scholar
  37. 37.
    Adolf R, Bercht F, Aronis ML, Lunardi LW, Schechter M, Sprinz E. Prevalence and risk factors associated with syphilis in a cohort of HIV positive individuals in Brazil. AIDS Care. 2012;24(2):252–8.Google Scholar
  38. 38.
    Ngou J, Gilham C, Omar T, et al. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women. J Acquir Immune Defic Syndr. 2015;68(2):162–8.Google Scholar
  39. 39.
    Heard I, Cubie HA, Mesher D, Sasieni P. Characteristics of HPV infection over time in European women who are HIV-1 positive. BJOG. 2013;120(1):41–9.Google Scholar
  40. 40.
    Lippman SA, Sucupira MC, Jones HE, et al. Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. Int J STD AIDS. 2010;21(2):105–9.Google Scholar
  41. 41.
    Coser J, da Rocha Boeira T, Simon D, Kazantzi Fonseca AS, Ikuta N, Lunge VR. Prevalence and genotypic diversity of cervical human papillomavirus infection among women from an urban center in Brazil. Genet Mol Res. 2013;12(4):4276–85.Google Scholar
  42. 42.
    Tamegao-Lopes BP, Sousa-Junior EC, Passetti F, Ferreira CG, de Mello WA, Duarte Silvestre RV. Prevalence of human papillomavirus infection and phylogenetic analysis of HPV-16 E6 variants among infected women from Northern Brazil. Infect Agent Cancer. 2014;9:25.Google Scholar
  43. 43.
    Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS. 2018;32(6):795–808.Google Scholar
  44. 44.
    Cianelli R, Villegas N. Social determinants of health for HIV among Hispanic women. Hisp Health Care Int. 2016;14(1):4–9.Google Scholar
  45. 45.
    Haley DF, Kramer MR, Adimora AA, et al. Relationships between neighbourhood characteristics and current STI status among HIV-infected and HIV-uninfected women living in the Southern USA: a cross-sectional multilevel analysis. Sex Transm Infect. 2017;93(8):583–9.Google Scholar
  46. 46.
    Howe CJ, Siegel H, Dulin-Keita A. Neighborhood environments and sexual risk behaviors for HIV infection among U.S. women: a systematic review. AIDS Behav. 2017;21(12):3353–65.Google Scholar
  47. 47.
    Boletim epidemiológico de sífilis [Internet]. Ministério da Saúde. Secretaria de Vigilância em Saúde—Departamento de Vigilância, Prevenção e Controle das IST, do HIV/Aids e das Hepatites Virais; 2017 [cited 2018 Apr 20]. http://portalarquivos.saude.gov.br/images/pdf/2017/novembro/13/BE-2017-038-Boletim-Sifilis-11-2017-publicacao-.pdf.
  48. 48.
    Pesquisa Nacional de Demografia e Saúde da Criança e da Mulher—PNDS 2006: dimensões do processo reprodutivo e da saúde da criança [Internet]. Brasília (BR): Ministério da Saúde. Centro Brasileiro de Análise e Planejamento; 2009 [cited 2018 Apr 21]. http://bvsms.saude.gov.br/bvs/publicacoes/pnds_crianca_mulher.pdf.
  49. 49.
    Tsuyuki K, Gipson JD, Urada LA, Barbosa RM, Morisky DE. Dual protection to address the global syndemic of HIV and unintended pregnancy in Brazil. J Fam Plann Reprod Health Care. 2016;42(4):271–9.Google Scholar
  50. 50.
    Cohen CR, Grossman D, Onono M, et al. Integration of family planning services into HIV care clinics: results one year after a cluster randomized controlled trial in Kenya. PLoS ONE. 2017;12(3):e0172992.Google Scholar
  51. 51.
    Diniz D, Medeiros M, Madeiro A. Pesquisa Nacional de Aborto 2016. Cien Saude Colet. 2017;22:653–60.Google Scholar
  52. 52.
    Barbosa RM, Pinho AA, Santos NS, Filipe E, Villela W, Aidar T. Induced abortion in women of reproductive age living with and without HIV/Aids in Brazil. Cien Saude Colet. 2009;14(4):1085–99.Google Scholar
  53. 53.
    Fusco CL, Silva RS, Andreoni S. Unsafe abortion: social determinants and health inequities in a vulnerable population in São Paulo, Brazil. Cad Saude Publ. 2012;28(4):709–19.Google Scholar
  54. 54.
    Maccarthy S, Rasanathan JJ, Crawford-Roberts A, Dourado I, Gruskin S. Contemplating abortion: HIV-positive women’s decision to terminate pregnancy. Cult Health Sex. 2014;16(2):190–201.Google Scholar
  55. 55.
    Dehlendorf C, Rodriguez MI, Levy K, Borrero S, Steinauer J. Disparities in family planning. Am J Obstet Gynecol. 2010;202(3):214–20.Google Scholar
  56. 56.
    Diniz SG, Araujo MJ. Commentary: reproductive health and rights in Brazil 20 years post-international conference on population and development. Glob Public Health. 2015;10(2):183–5.Google Scholar
  57. 57.
    Ally EZ, Laranjeira R, Viana MC, et al. Intimate partner violence trends in Brazil: data from two waves of the Brazilian National Alcohol and Drugs Survey. Rev Bras Psiquiatr. 2016;38(2):98–105.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Christine M. Zachek
    • 1
    • 2
    Email author
  • Lara E. Coelho
    • 3
  • Rosa M. S. M. Domingues
    • 3
  • Jesse L. Clark
    • 2
  • Raquel B. De Boni
    • 3
  • Paula M. Luz
    • 3
  • Ruth K. Friedman
    • 3
  • Ângela C. Vasconcelos de Andrade
    • 3
  • Valdilea G. Veloso
    • 3
  • Jordan E. Lake
    • 2
    • 4
  • Beatriz Grinsztejn
    • 3
  1. 1.School of MedicineUniversity of California San FranciscoSan FranciscoUSA
  2. 2.Department of MedicineUniversity of California Los Angeles David Geffen School of Medicine, South American Program in HIV Prevention Research (SAPHIR)Los AngelesUSA
  3. 3.Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo CruzRio de JaneiroBrazil
  4. 4.Department of MedicineThe University of Texas Health Science Center at Houston (UTHealth)HoustonUSA

Personalised recommendations